Massivemarkets

Nasdaq: IAM · Listed Oct 15, 2026

Iambic Therapeutics IPO

$14.61

▲ +2.74%today · -8.69% since the $16.00 IPO price

15-minute delayed · as of 6:27:39 AM EST on Nov 19, 2026

Iambic Therapeutics (IAM) priced its IPO at $16.00 a share and has traded on Nasdaq since Oct 15, 2026.

Last session · Nov 18, 2026

VWAP 14.82open 15.00fell below the open · 9:35back above the open · 9:55fell below the open · 10:05back above the open · 2:00fell below the open · 2:10back above the open · 2:45fell below the open · 3:05back above the open · 3:25fell below the open · 3:45high 15.32low 14.23$14.81volume · rising bars above the line, falling bars below9.43K9:304:00
Market cap
$699.64M
from the ticker reference
Volume
290.11K
shares, regular session
VWAP
$14.82
the last price is -1.43% from the volume-weighted average
Day range
14.10–15.42
low to high

The trading numbers are from the last session, Nov 18, 2026.

The debut race

IAM against other big listings, as the percent change from each stock's own IPO price.

The first 30 trading days. Each point is the last regular-session trade of a day.

+100%+200%IPOday 1day 5day 10day 15day 20day 25day 30Figma '25 +69.64%Reddit '24 +40.32%CoreWeave '25 +28.42%Arm '23 -3.06%Klarna '25 -7.33%IAM -7.44%

The IPO scoreboard

IAM against 6 other big listings: the return from each IPO's own price at the first trade, the close of day 1, day 5, and day 30.

IAM against other big IPOs: the money raised, and the return from each IPO price at the first trade, at the last trade of day 1, and on day 5 and day 30.
IPORaisedFirst tradeDay 1 closeDay 1 close, as a barDay 5Day 30
Iambic Therapeutics '26$150M+0.94%+18.19%-1.38%Not yet
Figma '25$1.22B+157.58%+252.42%+173.64%+69.64%
Circle '25$1.05B+122.58%+168.45%+278.18%+622.98%
Reddit '24$748M+38.24%+47.97%+69.90%+40.32%
Arm '23$5.23B+10.00%+23.76%+3.63%-3.06%
Klarna '25$1.37B+30.00%+16.14%+13.73%-7.33%
CoreWeave '25$1.5B-2.50%+0.02%+34.32%+28.42%

Day 1 is the last regular-session trade of the first day. Day 5 and day 30 are the last trade of the fifth and thirtieth trading day, counting the listing day as day 1. A cell fills in when that day has traded.

The offering

The Iambic Therapeutics IPO offers 9.38M shares to raise $150M, before any underwriters' option.

$13$15$16$17$19
Expected price range
$15 to $17
IPO price
$16.00
Shares offered
9.38M
Money raised
$150M
Listing date
Oct 15, 2026
Exchange
Nasdaq
Security
Ordinary Shares

Money raised, against the largest IPOs

  • Alibaba '14$21.77B
  • Facebook '12$18.41B
  • Rivian '21$11.93B
  • Uber '19$8.1B
  • Arm '23$5.23B
  • Iambic Therapeutics$150M

Where IAM ranks

Iambic Therapeutics's market cap against the largest US-listed companies.

Market cap, against the largest US-listed companies

  • AAPL$5.12T
  • MSFT$3.77T
  • NVDA$3.65T
  • GOOGL$3.47T
  • AMZN$2.9T
  • TSM$1.88T
  • AVGO$1.69T
  • META$1.58T
  • TSLA$1.52T
  • BRK.B$1.22T
  • IAM$699.64M

What comes after the IPO

Options, short interest, analyst ratings, and fund holdings are not available on day one. Each starts on its own date. A date marked est. follows usual market practice.

  1. Oct 15, 2026

    First trade

    Prices, bars, and snapshots

  2. Oct 20, 2026 · est.

    Options list

    Option chain and open interest

  3. Nov 4, 2026 · est.

    First short interest

    Short interest and daily short volume

  4. Nov 9, 2026 · est.

    Quiet period ends

    Analyst ratings and price targets

  5. Feb 14, 2027

    First 13F deadline

    Which funds hold the stock

  6. Date not set

    First earnings

    Income statement and ratios

  7. Apr 12, 2027 · est.

    Lock-up expires

    Insider sales on Form 4

Filings and the company

What Iambic Therapeutics has disclosed to the SEC, and the basic facts about the listing.

8-K filings

Material events that Iambic Therapeutics discloses to the SEC on Form 8-K.

  • Charter amendmentOct 16, 2026

    On October 16, 2026, Iambic Therapeutics, Inc. (the "Company") filed an amended and restated certificate of incorporation (the "Restated Certificate") with the Secretary of State of the State of Delaware in connection with the completion of the Company's initial public offering (the "IPO").

About Iambic Therapeutics

Iambic Therapeutics Inc is a technology and clinical-stage life sciences company developing novel medicines using its proprietary molecular superintelligence platform.

Ticker
IAM
Exchange
Nasdaq
Market
stocks
Type
CS
Currency
USD
Listed
Oct 15, 2026
Security
Ordinary Shares
Company website

Frequently asked questions

What was the Iambic Therapeutics IPO price?

$16.00 a share.

When did Iambic Therapeutics go public?

Iambic Therapeutics listed on Nasdaq on Oct 15, 2026 under the ticker IAM.

How much did the Iambic Therapeutics IPO raise?

$150M, before any underwriters' option.

How did Iambic Therapeutics open on its first day?

IAM first traded at $16.15, +0.94% from the IPO price of $16.00.

How did IAM close on its first day?

Its last regular-session trade was $18.91, +18.19% from the IPO price of $16.00.

What was the IAM first-day trading range?

$16.15 to $19.70 in the regular session.

How many IAM shares traded on the first day?

1.93M shares in the regular session.

How many shares did Iambic Therapeutics sell in its IPO?

9.38M shares.

What exchange is IAM listed on?

Iambic Therapeutics lists on Nasdaq under the ticker IAM.

Are the prices on this page real time?

No. Prices on this page are delayed 15 minutes. The Massive API and MCP server provide the most current data.

Build with Massive

Get the IAM data behind this page

The Massive endpoint behind each section of this page
What the page showsEndpoint
Offering terms and dates/vX/reference/ipos
Price/v3/snapshot
Chart, VWAP, and the market comparison/v2/aggs/ticker/IAM/range/5/minute
Market cap/v3/reference/tickers/IAM
News/v2/reference/news
Filings/vX/disclosures

Nothing on this page is investment advice. All data and content is provided for informational purposes under our Terms of Service.